Clinical remission with biologic therapies in severe asthma: a matter of definition
UK Severe Asthma Registry
UK Severe Asthma Registry
Citations
Altmetric:
Affiliation
Other Contributors
Publication date
2024-06-20
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
There is currently no evidence to support the use of maintenance and reliever therapy (MART) in patients with severe asthma and persistently elevated T2 biomarkers despite adherence to high dose ICS treatment https://bit.ly/42IOVbA
Citation
UK Severe Asthma Registry; McDowell PJ, McDowell R, Busby J, Eastwood MC, Patel PH, Jackson DJ, Mansur A, Patel M, Burhan H, Doe S, Chaudhuri R, Gore R, Dodd JW, Subramanian D, Brown T, Heaney LG. Clinical remission with biologic therapies in severe asthma: a matter of definition. Eur Respir J. 2024 Jun 20;63(6):2400160. doi: 10.1183/13993003.00160-2024. PMID: 38901893; PMCID: PMC11187314.
Type
Article